New drugs: varenicline tartrate, insulin glulisine, and insulin detemir.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences, PA, USA.
D001552:Benzazepines / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy; D017277:Drug Approval; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069057:Insulin Detemir; D049528:Insulin, Long-Acting; D018722:Nicotinic Agonists / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use*; D016540:Smoking Cessation; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence*; D000068580:Varenicline
D001552:Benzazepines; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000069057:Insulin Detemir; C479079:insulin glulisine; D000068580:Varenicline